Cogentix Medical Company Profile (NASDAQ:CGNT)

About Cogentix Medical (NASDAQ:CGNT)

Cogentix Medical logoCogentix Medical, Inc. is a global medical device company. The Company designs, develops, manufactures and markets a line of fiber-optic and video endoscopy products under the PrimeSight brand that are used across various surgical specialties in diagnostic and treatment procedures. The Company also offers the Urgent PC Neuromodulation System (Urgent PC Systems), a device that delivers percutaneous tibial nerve stimulation (PTNS), for the office-based treatment of overactive bladder (OAB). The Company also offers Macroplastique Implants, an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence that is primarily due to intrinsic sphincter deficiency. The PrimeSight flexible endoscopes are used in conjunction with the sterile, single-use microbial barrier known as the EndoSheath Protective Barrier. The PrimeSight endoscopy line also includes rigid endoscopes and portable peripherals, such as the video system and stroboscopy unit.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:CGNT
  • CUSIP: N/A
  • Web:
  • Market Cap: $165.69 million
  • Outstanding Shares: 60,914,000
Average Prices:
  • 50 Day Moving Avg: $2.32
  • 200 Day Moving Avg: $1.91
  • 52 Week Range: $1.37 - $3.26
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -73.50
  • P/E Growth: -6.31
Sales & Book Value:
  • Annual Revenue: $53.65 million
  • Price / Sales: 3.34
  • Book Value: $1.04 per share
  • Price / Book: 2.83
  • EBIDTA: $3.2 million
  • Net Margins: -35.88%
  • Return on Equity: -13.83%
  • Return on Assets: -10.53%
  • Current Ratio: 5.55%
  • Quick Ratio: 4.55%
  • Average Volume: 55,670 shs.
  • Beta: 0.69
  • Short Ratio: 2.03

Frequently Asked Questions for Cogentix Medical (NASDAQ:CGNT)

What is Cogentix Medical's stock symbol?

Cogentix Medical trades on the NASDAQ under the ticker symbol "CGNT."

How were Cogentix Medical's earnings last quarter?

Cogentix Medical, Inc. (NASDAQ:CGNT) posted its quarterly earnings data on Tuesday, August, 1st. The company reported $0.01 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.01) by $0.02. The company had revenue of $14.06 million for the quarter, compared to analysts' expectations of $13.90 million. Cogentix Medical had a negative return on equity of 13.83% and a negative net margin of 35.88%. View Cogentix Medical's Earnings History.

When will Cogentix Medical make its next earnings announcement?

Cogentix Medical is scheduled to release their next quarterly earnings announcement on Monday, November, 6th 2017. View Earnings Estimates for Cogentix Medical.

Who are some of Cogentix Medical's key competitors?

Who are Cogentix Medical's key executives?

Cogentix Medical's management team includes the folowing people:

  • Uri Geiger, Chairman of the Board
  • Darin Hammers, President, Chief Executive Officer, Director
  • Brett A. Reynolds, Chief Financial Officer, Senior Vice President, Principal Financial Officer, Principal Accounting Officer, Secretary
  • Kenneth H. Paulus, Director
  • Cheryl Pegus M.D., Director
  • Lewis C. Pell, Director
  • Kevin H. Roche, Director
  • Nachum Shamir, Director

Who owns Cogentix Medical stock?

Cogentix Medical's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Broadfin Capital LLC (1.83%), Perkins Capital Management Inc. (1.07%), DAFNA Capital Management LLC (0.59%), Vanguard Group Inc. (0.37%), Bard Associates Inc. (0.26%) and Manatuck Hill Partners LLC (0.25%). Company insiders that own Cogentix Medical stock include Kenneth A Samet and Lewis C Pell. View Institutional Ownership Trends for Cogentix Medical.

Who sold Cogentix Medical stock? Who is selling Cogentix Medical stock?

Cogentix Medical's stock was sold by a variety of institutional investors in the last quarter, including Vanguard Group Inc., Perkins Capital Management Inc. and Bard Associates Inc.. View Insider Buying and Selling for Cogentix Medical.

Who bought Cogentix Medical stock? Who is buying Cogentix Medical stock?

Cogentix Medical's stock was bought by a variety of institutional investors in the last quarter, including Broadfin Capital LLC and Northern Trust Corp. Company insiders that have bought Cogentix Medical stock in the last two years include Kenneth A Samet and Lewis C Pell. View Insider Buying and Selling for Cogentix Medical.

How do I buy Cogentix Medical stock?

Shares of Cogentix Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cogentix Medical's stock price today?

One share of Cogentix Medical stock can currently be purchased for approximately $2.94.

MarketBeat Community Rating for Cogentix Medical (NASDAQ CGNT)
Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  41 (Vote Outperform)
Underperform Votes:  95 (Vote Underperform)
Total Votes:  136
MarketBeat's community ratings are surveys of what our community members think about Cogentix Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cogentix Medical (NASDAQ:CGNT) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Cogentix Medical (NASDAQ:CGNT)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/7/2016Roth CapitalUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 9/19/2015 forward)


Earnings History for Cogentix Medical (NASDAQ:CGNT)
Earnings by Quarter for Cogentix Medical (NASDAQ:CGNT)
Earnings History by Quarter for Cogentix Medical (NASDAQ CGNT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/6/2017($0.01)N/AView Earnings Details
8/1/2017Q2 2017($0.01)$0.01$13.90 million$14.06 millionViewListenView Earnings Details
5/2/2017Q1 2017($0.01)($0.02)$13.14 million$12.95 millionViewListenView Earnings Details
3/9/2017Q4 2016($0.14)$13.81 million$13.23 millionViewListenView Earnings Details
11/3/2015Q216($0.07)($0.06)$11.45 million$11.80 millionViewN/AView Earnings Details
8/10/2015Q116($0.10)($0.07)$11.34 million$11.20 millionViewListenView Earnings Details
5/14/2015Q415($0.06)($0.15)$49.10 million$7.00 millionViewListenView Earnings Details
2/3/2014Q3 14($0.03)$4.00 million$4.50 millionViewN/AView Earnings Details
8/12/2013Q1 2014($0.05)$34.00 million$3.70 millionViewN/AView Earnings Details
11/5/2012Q213($0.06)($0.07)$3.85 million$3.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Cogentix Medical (NASDAQ:CGNT)
2017 EPS Consensus Estimate: ($0.02)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.01)($0.01)($0.01)
Q2 20171$0.00$0.00$0.00
Q3 20171($0.01)($0.01)($0.01)
Q4 20171$0.00$0.00$0.00
(Data provided by Zacks Investment Research)


Dividend History for Cogentix Medical (NASDAQ:CGNT)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Cogentix Medical (NASDAQ:CGNT)
Insider Ownership Percentage: 35.50%
Institutional Ownership Percentage: 12.67%
Insider Trades by Quarter for Cogentix Medical (NASDAQ:CGNT)
Institutional Ownership by Quarter for Cogentix Medical (NASDAQ:CGNT)
Insider Trades by Quarter for Cogentix Medical (NASDAQ:CGNT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/18/2016Kenneth A SametDirectorBuy25,000$2.47$61,750.00View SEC Filing  
6/10/2016Lewis C PellDirectorBuy13,291$0.95$12,626.45View SEC Filing  
6/1/2016Lewis C PellDirectorBuy894$0.75$670.50View SEC Filing  
5/31/2016Lewis C PellDirectorBuy500,000$0.79$395,000.00View SEC Filing  
5/21/2015Kevin H RocheDirectorBuy10,000$1.68$16,800.00View SEC Filing  
5/19/2015Kevin H RocheDirectorBuy10,000$1.60$16,000.00View SEC Filing  
2/20/2015Lewis C PellDirectorBuy20,000$0.51$10,200.00View SEC Filing  
2/19/2015Lewis C PellDirectorBuy10,000$0.48$4,800.00View SEC Filing  
2/18/2015Lewis C PellDirectorBuy30,000$0.45$13,500.00View SEC Filing  
2/13/2015Lewis C PellDirectorBuy20,000$0.47$9,400.00View SEC Filing  
2/11/2015Lewis C PellDirectorBuy35,000$0.46$16,100.00View SEC Filing  
12/23/2014Lewis C PellDirectorBuy80,000$0.85$68,000.00View SEC Filing  
12/22/2014Lewis C PellDirectorBuy40,000$0.86$34,400.00View SEC Filing  
9/23/2014Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
9/19/2014Lewis C PellDirectorBuy3,900$1.00$3,900.00View SEC Filing  
9/17/2014Lewis C PellDirectorBuy5,000$1.02$5,100.00View SEC Filing  
9/16/2014Lewis C PellDirectorBuy5,000$1.07$5,350.00View SEC Filing  
9/12/2014Lewis C PellDirectorBuy23,300$1.04$24,232.00View SEC Filing  
9/8/2014Lewis C PellDirectorBuy30,000$1.04$31,200.00View SEC Filing  
9/3/2014Lewis C PellDirectorBuy30,000$0.98$29,400.00View SEC Filing  
8/27/2014Lewis C PellDirectorBuy10,000$0.92$9,200.00View SEC Filing  
8/26/2014Lewis C PellDirectorBuy30,000$0.93$27,900.00View SEC Filing  
8/19/2014Lewis C PellDirectorBuy22,900$0.98$22,442.00View SEC Filing  
8/13/2014Lewis C PellDirectorBuy43,420$0.91$39,512.20View SEC Filing  
8/8/2014Lewis C PellDirectorBuy27,500$0.95$26,125.00View SEC Filing  
6/6/2014Lewis C PellDirectorBuy10,000$1.13$11,300.00View SEC Filing  
5/21/2014Lewis C PellDirectorBuy5,000$1.09$5,450.00View SEC Filing  
5/16/2014Lewis C PellDirectorBuy14,197$1.02$14,480.94View SEC Filing  
11/18/2013Lewis C PellDirectorBuy6,296$0.91$5,729.36View SEC Filing  
11/15/2013Lewis C PellDirectorBuy20,000$0.90$18,000.00View SEC Filing  
9/18/2013Lewis C PellDirectorBuy16,000$0.91$14,560.00View SEC Filing  
9/13/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/10/2013Lewis C PellDirectorBuy5,000$0.92$4,600.00View SEC Filing  
9/9/2013Lewis C PellDirectorBuy4,564$0.95$4,335.80View SEC Filing  
9/6/2013Lewis C PellDirectorBuy5,000$0.97$4,850.00View SEC Filing  
9/3/2013Lewis C PellDirectorBuy11,432$0.97$11,089.04View SEC Filing  
8/29/2013Lewis C PellDirectorBuy1,100$0.98$1,078.00View SEC Filing  
8/27/2013Lewis C PellDirectorBuy11,596$0.97$11,248.12View SEC Filing  
8/26/2013Lewis C PellDirectorBuy14,965$0.97$14,516.05View SEC Filing  
8/19/2013Lewis C PellDirectorBuy25,025$0.94$23,523.50View SEC Filing  
8/15/2013Lewis C PellDirectorBuy15,000$0.92$13,800.00View SEC Filing  
6/28/2013Lewis C PellDirectorBuy28,400$1.00$28,400.00View SEC Filing  
6/27/2013Lewis C PellDirectorBuy45,048$0.99$44,597.52View SEC Filing  
3/15/2013Lewis C PellDirectorBuy30,000$1.14$34,200.00View SEC Filing  
3/12/2013Lewis C PellDirectorBuy45,000$1.10$49,500.00View SEC Filing  
3/7/2013Lewis C PellDirectorBuy60,000$1.09$65,400.00View SEC Filing  
3/4/2013Lewis C PellDirectorBuy20,000$1.06$21,200.00View SEC Filing  
2/26/2013Lewis C PellDirectorBuy66,266$1.01$66,928.66View SEC Filing  
2/21/2013Lewis C PellDirectorBuy25,000$0.99$24,750.00View SEC Filing  
2/19/2013Lewis C PellDirectorBuy5,000$0.99$4,950.00View SEC Filing  
2/7/2013Lewis C PellDirectorBuy9,000$0.99$8,910.00View SEC Filing  
2/5/2013Lewis C PellDirectorBuy25,000$1.01$25,250.00View SEC Filing  
2/1/2013Lewis C PellDirectorBuy10,000$1.09$10,900.00View SEC Filing  
12/27/2012Lewis C PellDirectorBuy10,000$1.07$10,700.00View SEC Filing  
12/17/2012Lewis C PellDirectorBuy21,600$1.10$23,760.00View SEC Filing  
12/13/2012Lewis C PellDirectorBuy18,961$1.10$20,857.10View SEC Filing  
12/10/2012Lewis C PellDirectorBuy6,656$1.10$7,321.60View SEC Filing  
12/3/2012Lewis C PellDirectorBuy8,360$1.10$9,196.00View SEC Filing  
11/30/2012Lewis C PellDirectorBuy45,748$1.10$50,322.80View SEC Filing  
11/27/2012Lewis C PellDirectorBuy3,593$1.10$3,952.30View SEC Filing  
11/23/2012Lewis C PellDirectorBuy39,357$1.09$42,899.13View SEC Filing  
11/19/2012Lewis C PellDirectorBuy57,050$1.08$61,614.00View SEC Filing  
11/14/2012Lewis C PellDirectorBuy100,000$1.15$115,000.00View SEC Filing  
11/12/2012Lewis C PellDirectorBuy24,852$1.17$29,076.84View SEC Filing  
9/6/2012Lewis C PellDirectorBuy10,000$1.37$13,700.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Cogentix Medical (NASDAQ:CGNT)
Latest Headlines for Cogentix Medical (NASDAQ:CGNT)
DateHeadline logoAllscripts' Latest Initiative Eradicates Price Ambiguity - September 15 at 5:31 PM logoDaVita's (DVA) Green Initiatives Win a Coveted Golden Reward - September 15 at 3:59 AM logoCritical Analysis: Cogentix Medical (CGNT) and Thermo Fisher Scientific (TMO) - September 14 at 12:24 PM logoCogentix Medical Announces Cahaba GBA, LLC Extends Coverage for Urgent PC Maintenance Therapy - September 13 at 6:22 PM logoHead to Head Analysis: Cogentix Medical (CGNT) and The Competition - September 11 at 12:08 AM logoCivitas Solutions (CIVI) to Acquire Habilitative Services - August 24 at 5:14 PM logoWill Cogentix Medical (CGNT) Continue to Surge Higher? - August 9 at 5:20 PM logoCogentix Medical, Inc. (CGNT) Raised to "Buy" at Zacks Investment Research - August 4 at 5:26 PM logoEdited Transcript of CGNT earnings conference call or presentation 1-Aug-17 8:30pm GMT - August 2 at 5:53 PM logoCogentix Medical, Inc. (CGNT) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS - August 2 at 12:08 PM logoCogentix Medical Reports Strong Second Quarter Operating Results with 11% Urology Revenue Growth; Recently Executed Business Development Transactions Expected to Add Approximately 10 Points of Urology Revenue Growth in 2018 - August 1 at 5:49 PM logoCorporate News Blog - Cogentix Medical Acquires Genesis Medical to Further Increase Urology Products Revenue Growth Rate - July 28 at 6:47 PM logoPerkins Capital Management Inc Buys AmerisourceBergen Corp, Pentair PLC, Zagg Inc, Sells ... - July 27 at 4:35 PM logoCogentix Medical (CGNT) Acquires Genesis Medical - July 27 at 3:40 AM logoCogentix Medical Acquires Genesis Medical; Transaction to Further Increase Urology Products Revenue Growth Rate - July 26 at 5:44 PM logoCogentix Medical, Inc. (CGNT) Scheduled to Post Quarterly Earnings on Tuesday - July 25 at 7:20 AM logoCogentix Medical to Report Second Quarter Results on August 1, 2017 - July 20 at 6:57 PM logoCogentix Medical Signs Agreement to Launch Endo-Urology Product Line in US; Launch to Further Increase Urology Products Growth Rate During 2018 - July 18 at 6:40 PM logoZacks: Cogentix Medical, Inc. (CGNT) Given Consensus Rating of "Strong Buy" by Analysts - July 17 at 10:48 AM logoETFs with exposure to Cogentix Medical, Inc. : July 10, 2017 - July 10 at 5:06 PM logoCogentix Medical, Inc. (CGNT) Raised to "Hold" at Zacks Investment Research - July 4 at 6:32 PM logoETFs with exposure to Cogentix Medical, Inc. : June 28, 2017 - June 28 at 5:04 PM logoETFs with exposure to Cogentix Medical, Inc. : June 16, 2017 - June 16 at 4:59 PM logoCogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 - June 14 at 5:02 PM logoCogentix Medical (CGNT) Earns News Impact Score of -0.03 - May 4 at 9:17 AM logoCogentix Medical's (CGNT) CEO Darin Hammers on Q1 2017 Results - Earnings Call Transcript - May 3 at 9:17 PM logoCogentix Medical Inc (CGNT) Releases Quarterly Earnings Results, Misses Estimates By $0.01 EPS - May 3 at 2:47 PM logoEdited Transcript of CGNT earnings conference call or presentation 2-May-17 8:30pm GMT - May 3 at 9:14 AM logoInvestor Network: Cogentix Medical Inc. to Host Earnings Call - May 2 at 7:12 PM logoCogentix Medical Reports First Quarter Operating Results; Urology Revenue Up 11 Percent - May 2 at 7:12 PM logoCogentix Medical Inc (CGNT) Set to Announce Earnings on Tuesday - April 30 at 7:32 AM logoCogentix Medical (CGNT) Receiving Somewhat Positive Press Coverage, AlphaOne Reports - April 26 at 10:18 PM logoCogentix Medical (CGNT) Earning Very Positive Press Coverage, Report Shows - April 23 at 8:05 AM logoAsh Keswani Joins Cogentix Medical as SVP of Marketing and Business Development - April 20 at 4:24 PM logoCogentix Medical (CGNT) Receives Media Impact Score of 0.28 - April 20 at 4:11 PM logoCogentix Medical to Report First Quarter Results on May 2, 2017 - April 18 at 12:26 PM logoETFs with exposure to Cogentix Medical, Inc. : April 7, 2017 - April 7 at 4:15 PM logoCogentix Medical, Inc. :CGNT-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017 - April 7 at 8:56 AM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 10-K, Annual Report - March 30 at 4:41 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Ex - March 24 at 4:35 PM logoCogentix Medical (CGNT) Presents At 29th Annual ROTH Conference 2017 - March 14 at 4:08 PM logoEdited Transcript of CGNT earnings conference call or presentation 9-Mar-17 4:00pm GMT - March 10 at 2:52 AM logoCogentix Medical Reports Strong Fourth Quarter Operating Results - March 9 at 4:50 PM logoQ4 2016 Cogentix Medical Inc Earnings Release - Before Market Open - March 9 at 4:50 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and - March 9 at 4:50 PM logoCogentix Medical Inc (CGNT) Set to Announce Quarterly Earnings on Thursday - March 8 at 7:51 AM logoCogentix Medical to Participate in the 29th Annual ROTH Conference - March 6 at 10:38 AM logoCogentix Medical to Report Fourth Quarter Results on March 9, 2017 - February 23 at 4:13 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement - January 6 at 4:38 PM logoCOGENTIX MEDICAL INC /DE/ Files SEC form 8-K/A, Change in Directors or Principal Officers - January 3 at 10:59 PM



Cogentix Medical (CGNT) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff